Skip Navigation

Cardiovascular Research 1998 37(3):667-675; doi:10.1016/S0008-6363(97)00242-3
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Feng, Q.
Right arrow Articles by Arnold, J.M. O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, Q.
Right arrow Articles by Arnold, J.M. O
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure

Qingping Fenga,*, Xiangru Lua, Amanda J Fortina, Anders Petterssonb, Thomas Hednerb, Robert L Klinec and J.Malcolm O Arnolda

aCardiology Research Laboratory, London Health Sciences Centre, Departments of Medicine, Pharmacology and Toxicology, University of Western Ontario, Victoria Campus, 375 South Street, London, Ontario, Canada N6A 4G5
bDepartment of Clinical Pharmacology, University of Gothenburg, Gothenburg, Sweden
cCardiology Research Laboratory, Department of Physiology University of Western Ontario, London, Ontario, Canada

* Corresponding author. Tel.: (+1-519) 685 8300X5502; fax: (+1-519) 432 7367; e-mail: qfeng@julian.uwo.ca

Objective: NG,NG-dimethylarginine (asymmetric dimethylarginine, ADMA) is an important endogenous substance with potent inhibitory actions on nitric oxide (NO) synthesis. The present study was designed to determine circulating ADMA levels and endothelium-dependent, NO mediated vasodilation in a rat model of congestive heart failure (CHF). Methods: CHF was induced in rats by coronary artery ligation. Sham-operated rats served as normal controls. Plasma ADMA was determined by high performance liquid chromatography with fluorescence detection. Glomerular filtration rate (GFR) and renal blood flow (RBF) were measured by the clearance of inulin and p-aminohippuric acid, respectively. Endothelial function of the aorta was assessed in an organ bath. Results: Plasma levels of ADMA in rats with CHF (0.94±0.05 µmol/l) were significantly increased compared with sham-operated controls (0.75±0.06 µmol/l, p<0.05). Plasma levels of ADMA was negatively correlated with GFR (r=–0.65, p<0.05). Decreased endothelium-dependent relaxation to acetylcholine in the aorta of CHF was completely restored by L-arginine (300 µM) (p<0.01) while endothelium-independent relaxation to nitroprusside was not altered. ADMA potently inhibited endothelium-dependent relaxation in thoracic aorta of normal and CHF rats. The effect of ADMA was completely antagonized by L-arginine in both groups (p<0.01). Moreover, L-arginine improved endothelium-dependent relaxation in CHF rats in the presence of ADMA. Conclusions: An endogenous NO synthesis inhibitor ADMA is increased in the circulation of rats with CHF. The increased plasma levels of ADMA may contribute to the decreased endothelium-dependent relaxation in CHF, which is restored by L-arginine, possibly by competitive antagonism of ADMA.

KEYWORDS Asymmetric dimethylarginine (ADMA); L-Arginine; Nitric oxide synthase Inhibitor; Nitric oxide; Endothelium; Renal function; Congestive heart failure; Rat


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Sud, S. M. Wells, S. Sharma, D. A. Wiseman, J. Wilham, and S. M. Black
Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1407 - C1418.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Nicholls, Z. Wang, R. Koeth, B. Levison, B. DelFraino, V. Dzavik, O. W. Griffith, D. Hathaway, J. A. Panza, S. E. Nissen, et al.
Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction
Circulation, November 13, 2007; 116(20): 2315 - 2324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Chen, Y. Li, P. Zhang, J. H. Traverse, M. Hou, X. Xu, M. Kimoto, and R. J. Bache
Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2212 - H2219.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
S. Anthony, J. Leiper, and P. Vallance
Endogenous production of nitric oxide synthase inhibitors
Vascular Medicine, July 1, 2005; 10(1_suppl): S3 - S9.
[Abstract] [PDF]


Home page
Vasc MedHome page
S. Anthony, J. Leiper, and P. Vallance
Endogenous production of nitric oxide synthase inhibitors
Vascular Medicine, May 1, 2005; 10(2_suppl): S3 - S9.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. L. Tran, X. Lu, M. Lei, Q. Feng, and Q. Wu
Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1625 - H1631.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Vallance and J. Leiper
Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1023 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Achan, M. Broadhead, M. Malaki, G. Whitley, J. Leiper, R. MacAllister, and P. Vallance
Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase
Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): 1455 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Kaye, M. M. Parnell, and B. A. Ahlers
Reduced Myocardial and Systemic L-Arginine Uptake in Heart Failure
Circ. Res., December 13, 2002; 91(12): 1198 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
D. Tousoulis, C. Antoniades, C. Tentolouris, G. Goumas, C. Stefanadis, and P. Toutouzas
L-Arginine in cardiovascular disease: dream or reality?
Vascular Medicine, August 1, 2002; 7(3): 203 - 211.
[Abstract] [PDF]


Home page
CirculationHome page
Q. Feng, X. Lu, D. L. Jones, J. Shen, and J. M. O. Arnold
Increased Inducible Nitric Oxide Synthase Expression Contributes to Myocardial Dysfunction and Higher Mortality After Myocardial Infarction in Mice
Circulation, August 7, 2001; 104(6): 700 - 704.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A.C. Mendes Ribeiro, T.M.C. Brunini, J.C. Ellory, and G.E. Mann
Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure
Cardiovasc Res, March 1, 2001; 49(4): 697 - 712.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. B. Stathopulos, X. Lu, J. Shen, J. A. Scott, J. R. Hammond, D. G. McCormack, J. M. O. Arnold, and Q. Feng
Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H859 - H867.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Kaye, B. A. Ahlers, D. J. Autelitano, and J. P. F. Chin-Dusting
In Vivo and In Vitro Evidence for Impaired Arginine Transport in Human Heart Failure
Circulation, November 28, 2000; 102(22): 2707 - 2712.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. R. Ellis, R. A. Anderson, D. Lang, D. J. Blackman, R. H. K. Morris, J. Morris-Thurgood, I. F. W. McDowell, S. K. Jackson, M. J. Lewis, and M. P. Frenneaux
Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1474 - 1482.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Fujiwara, T. Osanai, T. Kamada, T. Katoh, K. Takahashi, and K. Okumura
Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension : Modulation of Nitric Oxide Synthesis by Salt Intake
Circulation, February 29, 2000; 101(8): 856 - 861.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Segarra, P. Medina, R. M. Ballester, P. Lluch, M. Aldasoro, J. M. Vila, S. Lluch, and D. A. Pelligrino
Effects of Some Guanidino Compounds on Human Cerebral Arteries • Editorial Comment
Stroke, October 1, 1999; 30(10): 2206 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. D. Thomas, W. Zhang, and R. G. Victor
Impaired Modulation of Sympathetic Vasoconstriction in Contracting Skeletal Muscle of Rats With Chronic Myocardial Infarctions : Role of Oxidative Stress
Circ. Res., April 27, 2001; 88(8): 816 - 823.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.